Prodrugs and their activation mechanisms for brain drug delivery
RSC Medicinal Chemistry · 2025 · 16 (3) · 1037-1048
DOI: 10.1039/d4md00788c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Ida Aaberg Lillethorup und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Technical University of Denmark 2800 Kongens Lyngby Denmark kaqvo@kemi.dtu.dk. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Danmarks Frie Forskningsfond, Novo Nordisk Fonden.
Abstract (Originalsprache)
Prodrugs are masked drugs that first become pharmacologically active after undergoing a structural change in vivo .
Autor:innen und Institutionen
- Department of Chemistry, Technical University of Denmark 2800 Kongens Lyngby Denmark kaqvo@kemi.dtu.dk.
ORCID-Profile: Katrine Qvortrup
Förderung
- Danmarks Frie Forskningsfond
- Novo Nordisk Fonden
Zitieren
APA
Lillethorup, I. A., Hemmingsen, A. V., & Qvortrup, K. (2025). Prodrugs and their activation mechanisms for brain drug delivery. RSC Medicinal Chemistry, 16(3), 1037-1048. https://doi.org/10.1039/d4md00788c
Vancouver
Lillethorup IA, Hemmingsen AV, Qvortrup K. Prodrugs and their activation mechanisms for brain drug delivery. RSC Medicinal Chemistry. 2025;16(3):1037-1048. doi:10.1039/d4md00788c
BibTeX
@article{Lillethorup2025,
author = {Lillethorup, Ida Aaberg and Hemmingsen, Andreas Victor and Qvortrup, Katrine},
title = {Prodrugs and their activation mechanisms for brain drug delivery},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {3},
pages = {1037--1048},
doi = {10.1039/d4md00788c}
}
EUVIMED